IR
Superintel
Overview
Markets
Watchlist
More
Invivo Therapeutics Hldgs Co
CUSIP: 46186M909 | 4 institutional holders
Watch
Quarters
Q1 2018
Q2 2017
Q1 2017
Q4 2016
Q3 2016
All
Compare
Detailed
Historical
Funds
Options
Short Interest
13D/13G
Peers
Targeting
Trading Summary
Profile